NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details
New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs, including popular brands such as Empagliflozin & Metformin Hydrochloride tablets by Micro Labs, Dapagliflozin & Glimepiride tablets by La Renon Healthcare, and Telmisartan & Chlorthalidone tablets by Cadila Pharmaceuticals, among others.
Among the newly regulated drugs, some widely used ones include Empagliflozin & Metformin Hydrochloride (Micro Labs Ltd.), which manage type 2 diabetes and control blood sugar levels. Dapagliflozin, Glimepiride & Metformin Hydrochloride (La Renon Healthcare) offer combination therapy for diabetes. Telmisartan, Cilnidipine & Chlorthalidone (Cadila Pharmaceuticals) are prescribed for hypertension, while Atorvastatin & Ezetimibe (Cadila Pharmaceuticals) lower cholesterol to reduce heart disease risk. Tranexamic Acid & Mefenamic Acid (Glensmith Labs) are commonly used for controlling excessive bleeding and providing pain relief.
In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the Table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Table
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Tranexamic Acid and Mefenamic Acid tablets | Each film coated tablet contains: Tranexamic Acid IP 500 mg Mefenamic Acid IP 250 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Glensmith Labs Pvt. Ltd. | 32.57 |
2 | Sitagliptin & Metformin Hydrochloride (Sustained Release) tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Primus Remedies Pvt. Ltd. | 12.84 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Metformin Hydrochloride IP 500 mg (as Sustained Release) | |||||
3 | Dapagliflozin, Glimepiride, Metformin Hydrochloride (extended release) tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Glimepiride IP 1 mg, Metformin Hydrochloride IP 500 mg (As Extended Release) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s La Renon Healthcare Pvt. Ltd. | 12.31 |
4 | Dapagliflozin, Glimepiride, Metformin Hydrochloride (Extended Release) tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Glimepiride IP 2 mg, Metformin Hydrochloride IP 500 mg (as Extended Release) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s La Renon Healthcare Pvt. Ltd. | 12.62 |
5 | Glimepiride, Voglibose & Metformin Hydrochloride (SR) tablets | Each uncoated bilayered tablet contains: Glimepiride IP 0.5 mg, Voglibose IP 0.2 mg, Metformin Hydrochloride IP 500 mg (as Sustained Release form) | 1 Tablet | M/s Windlas Biotech Limited/ M/s Mankind Pharma Ltd. | 9.12 |
6 | Bictegravir, Emtricitabine & Tenofovir Alafenamide Tablets | Each film coated tablet contains: Bictegravir Sodium eq. to Bictegravir 50 mg, Emtricitabine IP 200 mg Tenofovir Alafenamide Fumarate IP eq. to Tenofovir Alafenamide 25 mg | 1 Tablet | M/s Hetero Labs Limited / M/s Cipla Ltd. | 132.58 |
7 | Glimepiride & Metformin Hydrochloride (SR) tablets | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 1000 mg (as Sustained Release form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 9.40 |
8 | Glimepiride & Metformin Hydrochloride (SR) tablets | Each uncoated bilayered tablets contains: Glimepiride IP 3 mg, Metformin HCl IP 1000mg (Sustained Release form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 12.03 |
9 | Glimepiride & Metformin Hydrochloride (SR) tablets | Each uncoated bilayered tablets contains: Glimepiride IP 4 mg, Metformin HCl IP 1000mg (as Sustained Release form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 12.39 |
10 | Empagliflozin & Metformin Hydrochloride tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Micro Labs Ltd. | 15.84 |
11 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 12.5 mg | 1 Tablet | M/s Micro Labs Ltd. | 18.10 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Hydrochloride tablets | Metformin Hydrochloride IP 500 mg | ||||
12 | Empagliflozin & Metformin Hydrochloride tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Micro Labs Ltd. | 19.01 |
13 | Empagliflozin & Metformin Hydrochloride tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Micro Labs Ltd. | 11.38 |
14 | Linezolid for Oral Suspension | Each 5 ml of constituted suspension contains: Linezolid IP 100 mg | 1 ml | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 3.86 |
15 | Telmisartan, Cilnidipine & Chlorthalidone tablets | Each film coated tablet contains: Telmisartan IP 40 mg, Cilnidipine IP 10 mg, Chlorthalidone IP 12.50 mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Corona Remedies Pvt. Ltd. | 15.07 |
16 | Telmisartan, Cilnidipine & Chlorthalidone tablets | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP 6.25 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. /M/s Cadila Pharmaceuticals Ltd. | 14.69 |
17 | Telmisartan & Hydrochlorothiazide tablets | Each uncoated bilayered tablet contains: Telmisartan IP 40mg, Hydrochlorothiazide IP 12.5 mg | 1 Tablet | M/s Sano-Cito Therapeutics Inc- Unit-II / M/s Zuventus Healthcare Ltd. | 11.43 |
18 | Atorvastatin & Ezetimibe tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80 mg, Ezetimibe IP 10 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd. | 53.70 |
19 | Atorvastatin & Ezetimibe tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 80 mg, Ezetimibe IP 10 mg | 1 Tablet | M/s Windlas Biotech Ltd. / M/s Cadila Pharmaceuticals Ltd. | 53.70 |
20 | Diclofenac Sodium, Paracetamol & Chlorzoxazone tablets | Each uncoated tablet contains: Diclofenac Sodium IP 50mg, Paracetamol IP 325mg Chlorzoxazone USP 250mg | 1 Tablet | M/s Aagya Biotech Pvt. Ltd./ M/s Macleods Pharmaceuticals Ltd. | 6.55 |
21 | Levetiracetam tablets | Each film coated tablet contains: Levetiracetam IP 1000 mg | 1 Tablet | M/s Macleods Pharmaceuticals Ltd. | 35.94 |
22 | Clindamycin & Nicotinamide gel | Composition: Clindamycin Phosphate IP eq. to Clindamycin 1.0% w/w Nicotinamide IP 4.0% w/w | 1 Gm | M/s Pilco Healthcare Pvt. Ltd. /M/s | 7.35 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Glensmith Labs Pvt. Ltd | |||||
23 | Cefadroxil & Potassium Clavulanate dispersible tablets | Each uncoated dispersible tablet contains: Cefadroxil Monohydrate IP eq. to Anhydrous Cefadroxil 250 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5 mg | 1 Tablet | M/s Innova Captab Limited / M/s Indoco Remedies Ltd. | 9.72 |
24 | Cefadroxil & Potassium Clavulanate tablets | Each film coated tablet contains: Cefadroxil Monohydrate IP eq. to Anhydrous Cefadroxil 500 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg | 1 Tablet | M/s Innova Captab Limited / M/s Indoco Remedies Ltd. | 17.61 |
25 | Bilastine & Montelukast Suspension | Each 5 ml suspension contains: Bilastine IP 10 mg Montelukast Sodium IP eq. To Montelukast 4mg | 1 ml | M/s Synokem Pharmaceuticals Limited / M/s Intas Pharmaceuticals Limited | 1.69 |
26 | Amoxycillin & Potassium Clavulanate Oral Suspension | Each 5 ml of reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 600 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9 mg | 1 ml | M/s Malik Lifesciences Pvt. Ltd./ M/s Aurobindo Pharma Ltd. | 2.68 |
27 | Aspirin gastroresistant & Atorvastatin capsules | Each hard gelatin capsule Contain: Aspirin IP 75 mg (as gastroresistant tablet IP) Atorvastatin Calcium IP eq. to Atorvastatin 40 mg | 1 Capsule | M/s Windlas Biotech Ltd. / M/s Intas Pharmaceuticals Ltd. | 18.27 |
28 | Bisoprolol Fumarate and Amlodipine Besilate tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Amlodipine besilate IP eq. to Amlodipine 5 mg | 1 Tablet | M/s Macleods Pharmaceuticals Ltd. | 6.26 |
29 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Tablets | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 10mg Chlorpheniramine Maleate IP 2 mg | 1 Tablet | M/s East African (India) Overseas /M/s Medley Pharmaceuticals Ltd. | 4.81 |
30 | Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine HCl tablets | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5 mg Diphenhydramine HCl IP 25 mg Caffeine IP (anhydrous) 30 mg | 1 Tablet | M/s Juggat Pharma (Pharma Division of Jagdale Industries Pvt. Ltd.) | 4.22 |
31 | Paracetamol & Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 250 mg Mefenamic Acid IP 100 mg | 1 ml | M/s Yacca Lifesciences Pvt. Ltd./ M/s Intas Pharmaceuticals Ltd. | 0.88 |
32 | Mefenamic Acid & Paracetamol Suspension | Each 5 ml contains: Mefenamic Acid IP 100 mg Paracetamol IP 250 mg | 1 ml | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd. /M/s Aristo | 0.88 |
S. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (in Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Laboratories Pvt. Ltd. | |||||
33 | Mefenamic Acid & Paracetamol Suspension | Each 5 ml contains: Mefenamic Acid IP 50 mg Paracetamol IP 125 mg | 1 ml | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd. /M/s Aristo Laboratories Pvt. Ltd. | 0.73 |
34 | Paracetamol & Polmacoxib tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg | 1 Tablet | M/s Hetero Labs Ltd./ M/s Micro Labs Ltd. | 15.26 |
35 | Paracetamol & Polmacoxib tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg | 1 Tablet | M/s Hetero Labs Ltd./ M/s Abbott Healthcare Pvt. Ltd. | 15.26 |
36 | Paracetamol & Polmacoxib tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg | 1 Tablet | M/s Hetero Labs Limited/ M/s Mankind Pharma Ltd. | 15.26 |
37 | Polmacoxib and Paracetamol tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Polmacoxib IH 2 mg | 1 Tablet | M/s Hetero Labs Limited / M/s Torrent Pharmaceuticals Ltd. | 15.26 |
38 | Bisoprolol Fumarate and Amlodipine besilate tables | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Amlodipine besilate IP eq. to Amlodipine 5 mg | 1 Tablet | M/s Macleods Pharmaceuticals Ltd. | 8.54 |
39 | Cetirizine Drops | Each ml contains: Cetirizine Hydrochloride IP 10 mg | 1 ml | M/s Zuventus Healthcare Ltd. | 7.78 |
40 | Telmisartan, Cilnidipine & Chlorthalidone tablets | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP 6.25 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. /M/s German Remedies Pharmaceuticals Pvt. Ltd. | 14.92 |
41 | Atorvastatin, Clopidogrel & Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10 mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As Pellets) Aspirin IP 75 mg (as enteric coated Pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd. | 5.75 |
42 | Atorvastatin, Clopidogrel & Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (As Pellets) Aspirin IP 75 mg (as enteric coated Pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / M/s Ipca Laboratories Ltd. | 7.95 |
The Authority further added;
- The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table herein above.
- The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
- The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
- As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
- The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
- In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
- Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
